SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Acurx Pharmaceuticals, Inc. Reports Third Quarter 2026 results and provides business update

STATEN ISLAND, N.Y., Nov. 12, 2026 // -- Acurx Pharmaceuticals, Inc. (NASDAQ:ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of antibiotics for serious or life-threatening bacterial infections, announced today certain financial and operation…

ACXP

Related stories